AI-generated summary
This review article describes the authors' overview of how phototherapy may have anti-inflammatory effects in patients with ARDS and COVID-19. The authors note that cytokine storm is linked to COVID-19 severity and that anti-inflammatory therapies have helped recovery. The abstract states that new evidence suggests phototherapy may be effective, but it does not report any patient outcomes or pooled results.
- Who or what was studied
- Patients with COVID-19 and acute respiratory distress syndrome (ARDS)
- Limits stated in the abstract
- The abstract describes a review and reports no specific studies, sample sizes, wavelengths or outcome data, and the evidence it cites is described only as new and emerging.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.